Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medicago Inc MDCGF

Healthcare Biotechnology


GREY:MDCGF - Post by User

Medicago Inc > NVAX Trades 2 Millions Shares Today
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(306)
•••
Comment by beenthereon Feb 28, 2011 8:29pm
256 Views
Post# 18208843

RE: NVAX Trades 2 Millions Shares Today

RE: NVAX Trades 2 Millions Shares TodayAnd now we know:

Breaking News

Novavax Licenses Recombinant VLP Influenza Vaccine to LG Life Sciences for South Korea and Other Countries

19:30 EST Monday, February 28, 2011

-- 15 million dose South Korean market
-- LG to build manufacturing facility with 30 million dose influenza vaccine capacity


https://www.globeinvestor.com/servlet/WireFeedRedirect?cf=GlobeInvestor/config&vg=BigAdVariableGenerator&date=20110228&archive=prnews&slug=PH55777

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities